Home » Authors » Jim Shrine

Jim Shrine

Articles

ARTICLES

Swiss Firm GlycoVaxyn Raises $9.5M For Vaccine Programs

July 17, 2007

Swiss Firm GlycoVaxyn Raises $9.5M For Vaccine Programs

July 17, 2007

CODA Raises $7M In Series C For Protein Expression Platform

July 12, 2007

CODA Raises $7M In Series C For Protein Expression Platform

July 12, 2007

CureVac Completes €35M Round For mRNA Product Development

July 11, 2007

CureVac Completes 35M Round For mRNA Product Development

July 11, 2007

No Abstract

Reata Raises $25M In Series E To Fund Development Programs

July 9, 2007

Reata Raises $25M In Series E To Fund Development Programs

July 9, 2007

ViroPharma Starts Phase III Trial Of Camvia In Liver Transplants

July 6, 2007

ViroPharma Starts Phase III Trial Of Camvia In Liver Transplants

July 6, 2007

View All Articles by Jim Shrine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...